CD8+ TILs have been proven to be of favorable prognostic value in several kinds of tumors, including esophageal cancer, colon cancer, intrahepatic cholangiocarcinoma, and prostate cancer (34, 46, 47). Here, CD8A is linked to colonic neoplasm.